VS-7375 drug page Clinical trials

Trials with VS-7375

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
2Recruiting
2Countries
445Planned patients

Showing 1–2 of 2

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Recruiting Phase 2 150 patients NCT07659795

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab or panitumumab and cetuximab plus mFOLFOX in patients with metastatic KRAS G12D - mutated Colorectal Cancer

United States, Australia Jul 2026 – Dec 2028 Interventional
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recruiting Phase 1 295 patients NCT07020221

This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G12D-mutation.

United States, Australia Jun 2025 – Dec 2028 Interventional

Where the recruiting trials are